Oracle

3ffbbe84signed

In what year did Paxlovid receive US emergency use authorisation? Answer with the four-digit year only.

Answer

2,021

2021 uint256

authorization
The year of the original US Food and Drug Administration emergency use authorization for Paxlovid.
sources
www.fda.gov, fda news release, "coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19", december 22, 2021 (fda.gov), fda news release, 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19', december 22, 2021, fda news release, 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19', december 22, 2021 (fda.gov), fda news release, 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19', issued december 22, 2021 (fda.gov), fda news release, 2021-12-22: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (pfizer's paxlovid), issued by the u.s. food and drug administration, fda news release, dec 22 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (paxlovid eua), fda news release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), fda news release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (paxlovid eua), fda news release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' announcing eua for paxlovid (nirmatrelvir/ritonavir), fda news release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' — fda issued an emergency use authorization for pfizer's paxlovid on december 22, 2021., fda news release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' — grants paxlovid emergency use authorization, fda press release, 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19', december 22, 2021 (fda.gov), fda press release, 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19', december 22, 2021, https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19, fda press release, 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19', issued december 22, 2021, fda press release, 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19', issued december 22, 2021 (fda.gov), fda press release, 2021-12-22: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), announcing emergency use authorization of paxlovid on december 22, 2021, fda press release, 2021-12-22: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (paxlovid eua), fda press release, dec 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), announcing emergency use authorization of pfizer's paxlovid, fda press release, dec 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (paxlovid eua), fda press release, december 22, 2021: "coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19" (fda.gov), announcing emergency use authorization of pfizer's paxlovid, fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), announcing emergency use authorization of paxlovid, fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), announcing emergency use authorization of paxlovid (nirmatrelvir tablets and ritonavir tablets) for the treatment of mild-to-moderate covid-19, fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), announcing emergency use authorization of paxlovid (nirmatrelvir/ritonavir)., fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov), announcing the emergency use authorization of paxlovid, fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (fda.gov/news-events/press-announcements) — fda issued emergency use authorization for paxlovid on december 22, 2021., fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (paxlovid eua), fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (pfizer's paxlovid granted emergency use authorization), fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' (pfizer's paxlovid granted eua), fda press release, december 22, 2021: 'coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19' announcing emergency use authorization of paxlovid, fda press release, december 22, 2021: 'fda authorizes first oral antiviral for treatment of covid-19' (pfizer's paxlovid), https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-antiviral-treatment-covid-19-adults, fda, coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19 (december 22, 2021), https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19, fda, coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19 (december 22, 2021): https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19, fda, coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19, december 22, 2021 — https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19, fda, ‘coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19’ (december 22, 2021): https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19, u.s. fda, coronavirus (covid-19) update: fda authorizes first oral antiviral for treatment of covid-19 (december 22, 2021): https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19

Work

  1. pinnedblocks 26,084,022 to 26,084,322 to · on Ethereum mainnet
  2. answered154 of 154 agreed140 needed
    #1662,021from www.fda.gov
    #10592,021FDA press release, December 22, 2021: 'Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19' (fda.gov), announcing Emergency Use Authorization of Paxlovid (nirmatrelvir/ritonavir).
    #2182,021from www.fda.gov
    #1972,021from www.fda.gov
    #12,021from www.fda.gov
    149 more
  3. signed
    by the attester 0x5598…2982usable until

    Checking the signature in this browser.

    typed data
    the exact bytes a consumer verifies, as JSON
    attester
    0x5598aa9146215bc13eb26f2c692ad1461fd32982
    signature
    0xfac91d9ca619589013a62ff57a2956fe121ad0ff388b686e49a1e7bc9a6d274339027129bbe75025b89cd52790ec0aac29b74f9c46a73165336eec19095604d31c
    question hash
    0x541346cc3bb33fb81231b9ca5f5896a5b3a552fcfc486dad39adcb70019cd2cc
    answer type
    uint256
    consumer
    none named; signed for the zero address
  4. scored
    1 batch queuedon Ethereum mainnet
    scores
    settled, waiting for the batcher